NVDA
175.84
+1.77%↑
AAPL
251.14
+1.34%↑
MSFT
383.14
+0.45%↑
TSM
338.8
+2.99%↑
AVGO.US
322.68
+4.05%↑
NVDA
175.84
+1.77%↑
AAPL
251.14
+1.34%↑
MSFT
383.14
+0.45%↑
TSM
338.8
+2.99%↑
AVGO.US
322.68
+4.05%↑
NVDA
175.84
+1.77%↑
AAPL
251.14
+1.34%↑
MSFT
383.14
+0.45%↑
TSM
338.8
+2.99%↑
AVGO.US
322.68
+4.05%↑
NVDA
175.84
+1.77%↑
AAPL
251.14
+1.34%↑
MSFT
383.14
+0.45%↑
TSM
338.8
+2.99%↑
AVGO.US
322.68
+4.05%↑
NVDA
175.84
+1.77%↑
AAPL
251.14
+1.34%↑
MSFT
383.14
+0.45%↑
TSM
338.8
+2.99%↑
AVGO.US
322.68
+4.05%↑
24h
Šī brīža
Min
61.61
Max
65.98
Ienākumi | 40M 239M |
|---|---|
Pārdošana | 254M 7.1B |
P/E Sektora vidējais | 28.901 77.27 |
Peļņas marža | 3.386 |
Darbinieki | 147,979 |
EBITDA | -92M 378M |
Rekomendācijas | Pirkt (spēcīgs) |
|---|---|
Prognoze 12 mēnešiem | +19.08% upside |
Nākamie ieņēmumi | 2026. g. 6. maijs |
|---|
Tirgus kapitalizācija | -355M 24B |
|---|---|
Iepriekšējā atvēršanas cena | 59.52 |
Iepriekšējā slēgšanas cena | 64.96 |
By Acuity
50%
50%
148 / 376 Rangs Technology
By Trading Central
Pārliecība
Strong Bullish Evidence
35 / 38.55 Atbalsts un pretestība
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
2026. g. 23. marts 23:47 UTC
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update
DJ
Lasīt
2026. g. 23. marts 22:55 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
DJ
Lasīt
2026. g. 23. marts 21:51 UTC
Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update
DJ
Lasīt
2026. g. 23. marts 23:59 UTC
Global Equities Roundup: Market Talk
DJ
Lasīt
2026. g. 23. marts 23:59 UTC
Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk
DJ
Lasīt
2026. g. 23. marts 23:50 UTC
Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk
DJ
Lasīt
2026. g. 23. marts 23:37 UTC
Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk
DJ
Lasīt
2026. g. 23. marts 22:42 UTC
Global Equities Roundup: Market Talk
DJ
Lasīt
2026. g. 23. marts 22:42 UTC
Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk
DJ
Lasīt
2026. g. 23. marts 22:40 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18B
DJ
Lasīt
2026. g. 23. marts 22:23 UTC
Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk
DJ
Lasīt
2026. g. 23. marts 22:22 UTC
Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease
DJ
Lasīt
2026. g. 23. marts 22:21 UTC
Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales
DJ
Lasīt
2026. g. 23. marts 22:21 UTC
Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China
DJ
Lasīt
2026. g. 23. marts 22:20 UTC
Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD
DJ
Lasīt
2026. g. 23. marts 22:20 UTC
Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD
DJ
Lasīt
2026. g. 23. marts 22:19 UTC
Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders
DJ
Lasīt
2026. g. 23. marts 22:19 UTC
Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets
DJ
Lasīt
2026. g. 23. marts 22:18 UTC
Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD
DJ
Lasīt
2026. g. 23. marts 22:15 UTC
Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD
DJ
Lasīt
2026. g. 23. marts 22:08 UTC
Ebos Needs to Reset Its Gearing Targets -- Market Talk
DJ
Lasīt
2026. g. 23. marts 21:42 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Lasīt
2026. g. 23. marts 21:42 UTC
RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk
DJ
Lasīt
2026. g. 23. marts 21:32 UTC
WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK
DJ
Lasīt
2026. g. 23. marts 21:32 UTC
WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK
DJ
Lasīt
2026. g. 23. marts 21:32 UTC
WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK
DJ
Lasīt
2026. g. 23. marts 21:10 UTC
Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com
DJ
Lasīt
2026. g. 23. marts 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Lasīt
2026. g. 23. marts 20:50 UTC
Health Care Roundup: Market Talk
DJ
Lasīt
2026. g. 23. marts 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Lasīt
Cenas izmaiņa
By TipRanks
Prognoze 12 mēnešiem
Vidējais 73.4 USD 19.08%
Augstākais 75 USD
Zemākais 70 USD
Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Flex Ltd — pēdējo 3 mēnešu laikā.
By TipRanks
Pirkt (spēcīgs)
6 ratings
6
Pirkt
0
Turēt
0
Pārdot
Pamatojoties uz 6 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Flex Ltd — pēdējo 3 mēnešu laikā.
By Trading Central
Īstermiņā
Strong Bullish Evidence
Bullish events outweigh bearish events.
Vidējā termiņā
Bullish Evidence
Recent bullish events outweigh bearish events.
Ilgtermiņā
Bullish Evidence
All events are bullish.
By Acuity
Ziņu noskaņojums
Neutral
Volatilitāte
Zem vidējā
Ziņu apjoms (RCV)
Zem vidējā
Pārdošanas un administrēšanas izmaksas
Darbības izmaksas
Peļņa pirms nodokļu nomaksas
Pārdošana
Pārdošanas maksa
Bruto peļņa no pārdošanas
Procentu izdevumi par parādu
EBITDA
Pamatdarbības peļņa
$